bromocriptine has been researched along with naloxone in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (59.52) | 18.7374 |
| 1990's | 10 (23.81) | 18.2507 |
| 2000's | 4 (9.52) | 29.6817 |
| 2010's | 3 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Agnati, LF; Benfenati, F; Cortelli, P; D'alessandro, R; Ghisoli, E; Zampa, GA | 1 |
| Agnati, LF; Benfenati, F; Capelli, M; Cortelli, P; D'Alessandro, R; Galassi, E | 1 |
| Jamshidzadeh, A; Zarrindast, MR | 1 |
| Sagrillo, CA; Voogt, JL | 1 |
| Bertoni, P; Bianconi, L; Bocchi, R; Buonanno, G; Chiodera, P; Coiro, V; Marcato, A; Marchesi, M; Volpi, R; Vourna, S | 1 |
| Lincoln, GA; Ssewannyana, E | 1 |
| Bloom, FE; Koob, GF; Mitchiner, M; Weiss, F | 1 |
| Ahmed, HN; Gomaa, AA; Mohamed, LH | 1 |
| Cagnacci, A; Fioretti, P; Gambacciani, M; Melis, GB; Paoletti, AM; Soldani, R | 1 |
| Caffi, T; Cagnacci, A; Fioretti, P; Gambacciani, M; Melis, GB; Paoletti, AM | 1 |
| de Vries, HW; Hellebrekers, LJ; Lagerweij, E; van Wimersma Greidanus, TB | 1 |
| Bános, C; Földes, J; Gara, A; Székely, JI; Török, K; Váradi, A; Vargha, P | 1 |
| Kamada, S; Kubota, T; Saito, M; Tei, A; Tsuzuki, H | 1 |
| Martínez, JA; Milanés, MV; Vargas, ML | 1 |
| Carvey, P; Goetz, CG; Klawans, HL; Paulseth, JE | 1 |
| Garg, SK; Kulkarni, SK; Shukla, VK | 1 |
| Holzbauer, M; Racké, K; Sharman, DF | 1 |
| Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J | 2 |
| Bantutova, I; Iakimova, K; Koleva, E; Ovcharova, R | 1 |
| Bapna, JS; Ramaswamy, S | 1 |
| Boublik, JH; Funder, JW | 1 |
| Borsy, J; Gráf, L; Király, I; Tapfer, M | 1 |
| Benfenati, F; Catenacci, M; Ghisoli, E; Meringolo, D; Pancaldi, L | 1 |
| Manna, C; Piccione, E; Sesti, F | 1 |
| Martini, L; Sirinathsinghji, DJ | 1 |
| Benfenati, F; Ghisoli, E; Meringolo, D; Vecchi, P; Zampa, GA | 1 |
| Muscholl, E; Racké, K; Ritzel, H; Trapp, B | 1 |
| Agnati, LF; Benfenati, F; Bernardi, P; Calza, L; Capelli, M; Frank, G | 1 |
| Kulkarni, SK; Verma, A | 1 |
| Abs, R; Beckers, A; Verhelst, J | 1 |
| Deis, RP; Soaje, M | 1 |
| Caffarri, G; Chiodera, P; Cigarini, C; Coiro, V; Gramellini, D; Magotti, MG; Volpi, R | 1 |
| Tortonese, DJ | 1 |
| Mallmann, ES; Ribeiro, MF; Spritzer, PM | 1 |
2 review(s) available for bromocriptine and naloxone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Possibilities and limits of non-hormonal therapy of the menopausal syndrome].
Topics: Bromocriptine; Climacteric; Clonidine; Dopamine; Female; Gonadotropin-Releasing Hormone; Humans; Menopause; Naloxone; Norepinephrine; Prolactin; Sulpiride; Syndrome | 1984 |
1 trial(s) available for bromocriptine and naloxone
| Article | Year |
|---|---|
Regulation of body temperature in postmenopausal women: interactions between bromocriptine and the endogenous opioid system.
Topics: Body Temperature Regulation; Bromocriptine; Endorphins; Female; Humans; Menopause; Middle Aged; Naloxone; Random Allocation; Reference Values | 1989 |
39 other study(ies) available for bromocriptine and naloxone
| Article | Year |
|---|---|
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A study on the effects of interaction between naloxone and 2-Br-alpha-ergocryptine or clonidine on luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone levels in normal man serum.
Topics: Adult; Bromocriptine; Clonidine; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Naloxone; Prolactin; Receptors, Opioid; Thyrotropin | 1979 |
Naloxone potentiation of 2-Br-alpha-ergocryptine (CB 154) effects on GH secretion in man.
Topics: Adult; Bromocriptine; Drug Synergism; Feedback; Growth Hormone; Humans; Levodopa; Male; Naloxone; Receptors, Dopamine; Receptors, Opioid | 1979 |
Prolactin-secreting tumors and hypogonadism in men.
Topics: Animals; Bromocriptine; Chorionic Gonadotropin; Erectile Dysfunction; Female; Humans; Hypogonadism; Libido; Luteinizing Hormone; Male; Naloxone; Pituitary Neoplasms; Prolactin; Rats; Testosterone | 1979 |
Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
Topics: Animals; Bromocriptine; Depression, Chemical; Dose-Response Relationship, Drug; Male; Morphine; Naloxone; Physostigmine; Pilocarpine; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Yawning | 1992 |
Mechanisms for the stimulatory effects of opioidergic and serotonergic input signals on prolactin in pregnant rats.
Topics: alpha-Methyltyrosine; Animals; beta-Endorphin; Bromocriptine; Circadian Rhythm; Dopamine; Female; Haloperidol; Ketamine; Methyltyrosines; Naloxone; Pregnancy; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin | 1992 |
Restoration of normal gonadotropin responses to naloxone by chronic bromocriptine treatment in elderly men.
Topics: Adult; Aged; Aged, 80 and over; Aging; Bromocriptine; Follicle Stimulating Hormone; Humans; Kinetics; Luteinizing Hormone; Male; Middle Aged; Naloxone; Testosterone | 1991 |
Regulation of the photoperiod-induced cycle in the peripheral blood concentrations of beta-endorphin and prolactin in the ram: role of dopamine and endogenous opioids.
Topics: Animals; beta-Endorphin; Bromocriptine; Dopamine; Light; Male; Naloxone; Neuropeptides; Pimozide; Pituitary Gland; Prolactin; Sheep; Sulpiride | 1990 |
Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.
Topics: Alcohol Drinking; Animals; Bromocriptine; Conditioning, Operant; Dose-Response Relationship, Drug; Drinking; Ethanol; Male; Methysergide; Naloxone; Rats; Rats, Inbred Strains; Self Administration; Species Specificity | 1990 |
Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine.
Topics: Analgesics; Animals; Bromocriptine; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Naloxone; Reaction Time; Receptors, Dopamine; Sulpiride | 1989 |
Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal women.
Topics: Bromocriptine; Female; Humans; Luteinizing Hormone; Menopause; Middle Aged; Naloxone; Receptors, Dopamine; Receptors, Opioid | 1988 |
Volume-regulated arginine vasopressin release in conscious dogs. Evidence for dopaminergic or opioid modulation?
Topics: Animals; Arginine Vasopressin; Blood Pressure; Blood Volume; Bromocriptine; Dogs; Female; Heart Rate; Humans; Male; Naloxone; Receptors, Dopamine; Receptors, Opioid | 1988 |
Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by D-Met2,Pro5-enkephalinamide in man.
Topics: Adult; Bromocriptine; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Enkephalin, Methionine; Growth Hormone; Humans; Male; Methysergide; Naloxone; Prolactin; Thyrotropin; Time Factors | 1986 |
[Study on the neuroendocrinological control of prolactin release in early puerperium].
Topics: Bromocriptine; Cimetidine; Dopamine; Endorphins; Female; Histamine; Humans; Hypothalamo-Hypophyseal System; Metoclopramide; Naloxone; Pituitary-Adrenal System; Postpartum Period; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone | 1987 |
[Interaction of opioid peptides and the dopaminergic system in the myenteric plexus of the guniea pig ileum].
Topics: Animals; Apomorphine; Bromocriptine; Drug Interactions; Endorphins; Guinea Pigs; Haloperidol; Hydroxydopamines; Ileum; In Vitro Techniques; Myenteric Plexus; Naloxone; Oxidopamine; Receptors, Dopamine | 1987 |
L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Bromocriptine; Clonazepam; Disease Models, Animal; Guinea Pigs; Haloperidol; Lisuride; Morphine; Myoclonus; Naloxone; Scopolamine; Tremorine | 1986 |
Antagonism by naloxone of anti-tremorine effect of bromocriptine in mice.
Topics: Animals; Bromocriptine; Male; Mice; Naloxone; Scopolamine; Tremor; Tremorine | 1987 |
Release of endogenous 5-hydroxytryptamine from the intermediate lobe of the rat pituitary gland is inhibited by endogenous dopamine.
Topics: Animals; Bromocriptine; Dopamine; Male; Naloxone; Neural Inhibition; Pituitary Gland, Posterior; Rats; Serotonin; Sulpiride | 1986 |
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats | 1986 |
[Effect on morphine hyperthermia of dopaminergic agents].
Topics: Animals; Apomorphine; Body Temperature; Bromocriptine; Drug Interactions; Fever; Haloperidol; Male; Methotrimeprazine; Morphine; Naloxone; Rats; Rats, Inbred Strains; Rectum; Time Factors | 1985 |
Analgesic effect of metoclopramide and its mechanism.
Topics: Analgesics; Animals; Bromocriptine; Dose-Response Relationship, Drug; Male; Metoclopramide; Mice; Naloxone; Prolactin; Yohimbine | 1986 |
Interaction of dopamine receptor ligands with subtypes of the opiate receptor.
Topics: Animals; Binding, Competitive; Brain; Bromocriptine; Dopamine Antagonists; Drug Interactions; Haloperidol; In Vitro Techniques; Ligands; Male; Membranes; Metoclopramide; Naloxone; Pimozide; Prochlorperazine; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Opioid; Tritium | 1984 |
Further evidence for the neuroleptic-like activity of gamma-endorphin.
Topics: Animals; Antipsychotic Agents; Bromocriptine; Dextroamphetamine; Endorphins; gamma-Endorphin; Haloperidol; Humans; Kinetics; Male; Morphine; Naloxone; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1981 |
Effects of dopaminergic receptor stimulation and opioid receptor blockade on GH incretion: preliminary findings.
Topics: Bromocriptine; Drug Synergism; Growth Hormone; Humans; Kinetics; Male; Naloxone; Receptors, Dopamine; Receptors, Opioid; Reference Values | 1980 |
Effects of bromocriptine and naloxone on plasma levels of prolactin, LH and FSH during suckling in the female rat: responses to gonadotrophin releasing hormone.
Topics: Animals; Bromocriptine; Female; Follicle Stimulating Hormone; Lactation; Luteinizing Hormone; Naloxone; Pituitary Hormone-Releasing Hormones; Pregnancy; Prolactin; Rats; Rats, Inbred Strains | 1984 |
Effect of various neuroactive drugs on bromocriptine concentration in the striatum of rats.
Topics: Animals; Bromocriptine; Central Nervous System Agents; Corpus Striatum; Levodopa; Naloxone; Nervous System; Rats | 1984 |
[Effects of interaction between 2-Br-alpha-ergocriptine (CB 154) and naloxone on the control of insulin secretion in normal men].
Topics: Bromocriptine; Humans; Insulin; Insulin Secretion; Male; Naloxone; Reference Values | 1980 |
Dopaminergic modulation of evoked vasopressin release from the isolated neurohypophysis of the rat. Possible involvement of endogenous opioids.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine; Electric Stimulation; Endorphins; Female; Flupenthixol; In Vitro Techniques; Naloxone; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Tetrodotoxin; Vasopressins | 1982 |
Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154).
Topics: Acromegaly; Adult; Bromocriptine; Drug Interactions; Female; Growth Hormone; Humans; Male; Middle Aged; Naloxone; Prolactin; Secretory Rate | 1981 |
Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice.
Topics: Animals; Apomorphine; Azepines; Bromocriptine; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Mice; Mice, Inbred Strains; Morphine; Morphine Dependence; Naloxone; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate | 1995 |
The effect of naloxone and metoclopramide on the secretion of luteinizing hormone in a hyperprolactinemic hypogonadotropic postmenopausal woman.
Topics: Aged; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Hypogonadism; Injections, Intravenous; Luteinizing Hormone; Metoclopramide; Naloxone; Narcotic Antagonists; Pituitary Neoplasms; Postmenopause; Prolactin; Prolactinoma | 1995 |
A modulatory role of endogenous opioids on prolactin secretion at the end of pregnancy in the rat.
Topics: Animals; Bromocriptine; Endorphins; Female; Gestational Age; Mifepristone; Naloxone; Oxymorphone; Pregnancy; Pregnancy, Animal; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar | 1994 |
Age-related decrease in the opioid control of LH secretion during reproductive years in normal women.
Topics: Adult; Aging; Bromocriptine; Dopamine Agonists; Female; Humans; Luteinizing Hormone; Menstrual Cycle; Middle Aged; Naloxone; Narcotic Antagonists | 1997 |
Interaction between hypothalamic dopaminergic and opioidergic systems in the photoperiodic regulation of pulsatile luteinizing hormone secretion in sheep.
Topics: Animals; Bromocriptine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Endorphins; Hypothalamus; Luteinizing Hormone; Male; Naloxone; Narcotic Antagonists; Photoperiod; Pulsatile Flow; Sexual Behavior, Animal; Sheep; Sulpiride | 1999 |
Effect of serotonin depletion by p-chlorophenylalanine on serum prolactin levels in estrogen-treated ovariectomized rats: insights concerning the serotoninergic, dopaminergic and opioid systems.
Topics: Animals; Bromocriptine; Dopamine; Dopamine Agonists; Estrogens; Female; Fenclonine; Naloxone; Narcotic Antagonists; Opioid Peptides; Ovariectomy; Prolactin; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists | 2001 |